Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manu Sharma

Showing results (291-300 of 325) with videos related to

Pageof 33
Sort By:
Neurobiology of Aging|December 29, 2009
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseRejko Krüger, Manu Sharma, Olaf Riess, et al.
Frontiers in Neurology|July 14, 2020
Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchRoopa Rajan, K P Divya, Rukmini Mridula Kandadai, et al.
Annals of Neurology|April 26, 2021
Investigation of Autosomal Genetic Sex Differences in Parkinson's DiseaseCornelis Blauwendraat, Hirotaka Iwaki, Mary B Makarious, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2020
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel DiseaseAlexey A Shadrin, Sören Mucha, David Ellinghaus, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinaseEmil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
Annals of Neurology|May 29, 2009
SNCA variants are associated with increased risk for multiple system atrophySonja W Scholz, Henry Houlden, Claudia Schulte, et al.
The Lancet. Neurology|April 13, 2024
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analysesEmil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
Neurobiology of Aging|June 13, 2017
NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseasesCornelis Blauwendraat, Faraz Faghri, Lasse Pihlstrom, et al.
Neurobiology of Aging|November 6, 2016
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyLisa Wang, Michael G Heckman, Jan O Aasly, et al.
Neurobiology of Aging|July 26, 2011
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's diseaseManu Sharma, Demetrius M Maraganore, John P A Ioannidis, et al.
Pageof 33

Showing results (291-300 of 325) with videos related to

Sort By:
Pageof 33
Neurobiology of Aging|December 29, 2009
A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's diseaseRejko Krüger, Manu Sharma, Olaf Riess, et al.
Frontiers in Neurology|July 14, 2020
Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchRoopa Rajan, K P Divya, Rukmini Mridula Kandadai, et al.
Annals of Neurology|April 26, 2021
Investigation of Autosomal Genetic Sex Differences in Parkinson's DiseaseCornelis Blauwendraat, Hirotaka Iwaki, Mary B Makarious, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 27, 2020
Shared Genetics of Multiple System Atrophy and Inflammatory Bowel DiseaseAlexey A Shadrin, Sören Mucha, David Ellinghaus, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and activates LRRK2 kinaseEmil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
Annals of Neurology|May 29, 2009
SNCA variants are associated with increased risk for multiple system atrophySonja W Scholz, Henry Houlden, Claudia Schulte, et al.
The Lancet. Neurology|April 13, 2024
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analysesEmil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
Neurobiology of Aging|June 13, 2017
NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseasesCornelis Blauwendraat, Faraz Faghri, Lasse Pihlstrom, et al.
Neurobiology of Aging|November 6, 2016
Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter studyLisa Wang, Michael G Heckman, Jan O Aasly, et al.
Neurobiology of Aging|July 26, 2011
Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's diseaseManu Sharma, Demetrius M Maraganore, John P A Ioannidis, et al.
Pageof 33